Sapere Bio, Inc.

NC Doing business as Sapere Bio ASN

UEI
Q3LKKRH87ES9
CAGE
6XNY3
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
400 Park Offices Dr #113, Research Triangle Park, NC 27709, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant awards

Similar vendors

About the company

Sapere Bio, Inc. - doing business as Healthspan DX - is a corporate entity that provides medical and scientific research services to the U.S. federal government. Through past prime federal contract awards, Sapere Bio has provided measurement services of biomarkers related to cellular senescence and aging from tissue samples. These services were provided to the National Institutes of Health National Institute on Aging with a period of performance from March 2021 to March 2022.

Through past prime federal grant awards, Sapere Bio has conducted medical research to develop models for predicting chemotherapy-induced peripheral neuropathy risk in cancer patients. This research aims to identify patients likely to develop acute and chronic peripheral neuropathy from taxane chemotherapy regimens. The research is funded by the National Institutes of Health National Institute on Aging for the period August 2021 to August 2024.

Additionally, Sapere Bio has participated as a sub awardee on federal grants from the Georgia Tech Research Corporation. In this capacity, Sapere Bio has provided scientific expertise, sample processing services, and data analysis of the p16 cellular senescence biomarker. The goal of this research is to elucidate senescence dynamics over the human lifespan and correlate senescence with age-related dysfunction and disease.

Quick answers

Is Sapere Bio, Inc. registered in SAM.gov?

Yes. Sapere Bio, Inc.'s SAM.gov registration is active through November 30, 2026.

What is Sapere Bio, Inc.'s most recent federal award?

Sapere Bio, Inc.'s most recent federal grant award is Measuring cellular senescence to predict and prevent peripheral neuropathy (R44AG072994), from National Institute on Aging (NIH), on September 15, 2021.

On GovTribe

See Sapere Bio, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors